"If we got a bid, management would not stand in the way," said Mr Lynch.
Message 17019433
Well, they're going to get bids.
Geeze, at $4B market cap, even a concrete company would bid for them. But, assuming any bidder would be a pharmaceutical, an acquisition of Elan would be accretive to earnings at 3-4 times the current share price, and that's without allowing for cash on hand, plant and equipment, sales force, intellectual property, and upside from 55 JV's. Let the bidding begin, probably at $50 USD. |
